After a week of taking Hetropoxa, platelets should normally show an upward trend. However, depending on the physical condition of the people taking the drug and the efficacy of the drug, some people may experience ineffectiveness after taking the drug.
Hetropoxa is mainly used for the treatment of chronic primary immune thrombocytopenia that has not responded well to glucocorticoids, immunoglobulins and other treatments, and it can also be used for the treatment of severe aplastic anemia that has not responded well to immunosuppressive treatments.
The use of the process may cause anemia, myocardial infarction, lung nodules and other adverse reactions. Therefore, it should be used with caution in people with hepatic impairment and in pregnant and lactating women.
After 1~2 weeks of taking the drug, the patient will experience different degrees of platelet elevation, which can effectively promote the generation of platelets in the body, thus helping to improve hematopoietic function. However, depending on the degree of hematopoietic impairment and the sensitivity of the drug, some people may not experience platelet elevation after taking the drug, so it is necessary to change the drug for treatment.
In the hematopoietic function of treatment, should be under the guidance of the doctor to choose the appropriate drugs carefully use drugs. Hetropoxa’s should be used in accordance with medical advice.